Markets

​Embattled drugmaker Valeant names new CEO

/ AP

Severe storms threaten central U.S., and other MoneyWatch headlines

Embattled drugmaker Valeant Pharmaceuticals (VRX) has chosen Perrigo Co. CEO Joseph C. Papa to become its new CEO, replacing J. Michael Pearson.

Valeant said Monday that the 60-year-old executive will start early next month.

The Wall Street Journal reported last week that Valeant was finalizing a contract with Papa.

Valeant Pharmaceuticals International Inc. said last month that Pearson was leaving but would stay until his replacement is hired.

Pearson is scheduled to be deposed later this week by a Senate committee investigating the causes of soaring prescription medicine prices.

Valeant's stock jumped in early morning trading. The stock has plunged from all-time high prices it hit last year, as the Canadian drugmaker dealt with headaches like rising debt levels and federal probes into its accounting and business practices.

© 2016 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.

f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.